Models of PTSD and traumatic stress: the importance of research "from bedside to bench to bedside"

被引:10
作者
Ursano, Robert J. [1 ]
Li, He [1 ]
Zhang, Lei [1 ]
Hough, Chris J. [1 ]
Fullerton, Carol S. [1 ]
Benedek, David M. [1 ]
Grieger, Thomas A. [1 ]
Holloway, Harry C. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA
来源
STRESS HORMONES AND POST TRAUMATIC STRESS DISORDER: BASIC STUDIES AND CLINICAL PERSPECTIVES | 2007年 / 167卷
关键词
animal models; PTSD; posttraumatic stress disorder; neurobiology;
D O I
10.1016/S0079-6123(07)67014-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The epidemiology and psychology of PTSD noted above is not often considered in neurobiological models of PTSD. Neurobiological models tend to focus on symptoms. This is an important perspective but it does not capture the brains total response to traumatic events. Similarly, neurobiologists have rarely used the extensive knowledge of animal behavioral responses to stress as a means to define the human stress phenomenology, looking for the human equivalent (rather than the other way around). The development of animal models for PTSD and other traumatic stress-related brain changes is an important part of advancing our neurobiological understanding of the disease process as well as recovery, resilience, and possible therapeutic targets. Animal models should address symptoms but also other aspects of PTSD that are seen in clinical care including the waxing and waning of symptoms, Understanding "forgetting", toxic exposure, failure to recover and how the neural systems fail rather than function are important perspectives on developing animal models. The cognitive process of identification is another important animal model to develop. Using these perspectives recent work has shown new avenues for understanding the trauma response in animal models and human brain tissue of individuals with PTSD. The 5-HT2A receptor and p I I protein and associated regulators are avenues of new investigation that warrant study and consideration in models of PTSD.
引用
收藏
页码:203 / 215
页数:13
相关论文
共 93 条
  • [1] Effects of systemic injections of Vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats
    Adamec, R
    Bartoszyk, GD
    Burton, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (1-2) : 65 - 77
  • [2] SLEEP-WAKEFULNESS PATTERNS IN THE HELPLESS RAT
    ADRIEN, J
    DUGOVIC, C
    MARTIN, P
    [J]. PHYSIOLOGY & BEHAVIOR, 1991, 49 (02) : 257 - 262
  • [3] Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus
    Amat, J
    Baratta, MV
    Paul, E
    Bland, ST
    Watkins, LR
    Maier, SF
    [J]. NATURE NEUROSCIENCE, 2005, 8 (03) : 365 - 371
  • [4] Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat
    Amat, J
    Matus-Amat, P
    Watkins, LR
    Maier, SF
    [J]. BRAIN RESEARCH, 1998, 812 (1-2) : 113 - 120
  • [5] Input-specific LTP and depotentiation in the basolateral amygdala
    Aroniadou-Anderjaska, V
    Post, RM
    Rogawski, MA
    Li, H
    [J]. NEUROREPORT, 2001, 12 (03) : 635 - 640
  • [6] PAROXETINE BINDING IN THE BLOOD-PLATELETS OF POSTTRAUMATIC-STRESS-DISORDER PATIENTS
    ARORA, RC
    FICHTNER, CG
    OCONNOR, F
    CRAYTON, JW
    [J]. LIFE SCIENCES, 1993, 53 (11) : 919 - 928
  • [7] Blank T, 1996, J NEUROSCI RES, V45, P153, DOI 10.1002/(SICI)1097-4547(19960715)45:2<153::AID-JNR7>3.0.CO
  • [8] 2-9
  • [9] Stress impairs α1A adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala
    Braga, MFM
    Aroniadou-Anderjaska, V
    Manion, ST
    Hough, CJ
    Li, H
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (01) : 45 - 58
  • [10] Deficits in verbal declarative memory function in women with childhood sexual abuse-related posttraumatic stress disorder
    Bremner, JD
    Vermetten, E
    Afzal, N
    Vythilingam, M
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2004, 192 (10) : 643 - 649